Contraindications: • Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1; • Patients aged under 15 years. • Pregnant women during the third trimester of pregnancy. • Breast-feeding mothers. • Patients who have previously shown hypersensitivity reactions (e.g. bronchospasm, asthma, rhinitis, angioedema or urticaria) in response to acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs). • History of gastrointestinal bleeding or perforation related to previous NSAIDs therapy. • Active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding). • Cerebrovascular or other bleeding. • Unexplained haematopoietic abnormalities. • Severe hepatic insufficiency. • Severe renal failure. • Severe heart failure (NYHA Class IV). • Severe cardiovascular disorders, coronary heart disease (heart disease, hypertension, angina pectoris), tachycardia, hyperthyroidism, diabetes, pheochromocytoma. • History of stroke or presence of risk factors for stroke (because of the α-sympathomimetic activity of pseudoephedrine hydrochloride). • Risk of closed-angle glaucoma. The following information is an educational aid only. It is not indicated as medical advice or treatment. Consult your Doctor on safety and effectiveness.